FDA Inspection
CBI Laboratories, Inc. dba Voyant Beauty LLC.CBI Laboratories, Inc. dba Voyant Beauty LLC. – FDA Inspection, Feb 14, 2014
Record Details
This FDA Inspection record concerns CBI Laboratories, Inc. dba Voyant Beauty LLC., with an inspection on February 14, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 14, 2014
- Product Type
- Drugs
View Company Profile
ID · 220cf0f2-2c48-41fc-a058-9381057154f4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 862837
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.166(b)Adequate number of batches on stability
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CBI Laboratories, Inc. dba Voyant Beauty LLC.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 1, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CBI Laboratories, Inc. dba Voyant Beauty LLC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.